Feb 24, 2025

Stem cell test predicts leukemia relapse just 30 days after transplant

Sep 05, 2024

Pharmacist and health policy specialist comes full circle as patient partner

Jun 26, 2023

Why some patients with a rare but deadly leukemia fare much better than others

Mar 07, 2022

New gene signature test predicts risk of acute myeloid leukemia relapse

Mar 04, 2022

Made-in-Canada CAR-T cells save lives in promising clinical trial

Nov 17, 2020

Towards healthier lives for childhood leukemia survivors

Sep 16, 2020

Scientists discover mechanism of bone loss caused by acute lymphocytic leukemia, identify targeted therapy for children

Sep 30, 2019

Hamilton study discovers new approach to target cells at the root of leukemia

Apr 24, 2019

Targeting fat production could help tackle leukemia

Jan 29, 2019

First-in-class drug for blood cancers discovered by Ontario researchers receives record-setting industry investment

Aug 07, 2018

Data integration for the future of precision oncology

Jul 10, 2018

Researchers find early indicators of leukemia in genomes up to 10 years before symptoms surfaced

Oct 20, 2017

Old drug, new trick: study finds common diabetes drug could help fight leukemia

Jul 11, 2017

New multi-disciplinary team taking a stem cell-based approach to target acute leukemia

Jun 28, 2017

Ontario researchers identify rare therapy-resistant stem cells linked to AML patient relapse

May 25, 2017

OICR launches five all-star teams of Ontario scientists to tackle some of the deadliest forms of cancer

May 25, 2017

OICR launches five large-scale Ontario research initiatives to combat some of the most deadly cancers

Apr 25, 2017

Dr. John Dick presented with CIHR Gold Leaf Award for Discovery

Dec 07, 2016

Cancer stem cell scientists create tool to aid in planning treatment for leukemia

Aug 09, 2016

Patients need access to more stem cells for transplants. Researchers have now identified the genetic switch that could turn on the supply

May 05, 2016

A new method to grow stem cells for cancer patients

Dec 08, 2015

FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia

Dec 08, 2015

FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia

Oct 14, 2015

OICR, UHN, Novera Therapeutics Announce Collaboration with Johnson & Johnson Innovation on Drug Discovery and Development for Haematological Cancers